- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04698733
Veteran Affairs Osteoarthritis Knee Study
Efficacy of a Pulsed Microcurrent in the Non-Invasive Treatment of Knee Pain From Osteoarthritis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The primary objective of this study is to document the possible short- and long-term decrease in pain as scored by participants on a Numeric Rating Scale (NRS) after use of Avazzia PRO-Sport Ultra® device with pulsed microcurrent in patients with osteoarthritis of the knee.
Patients with a clinical diagnosis of Osteoarthritis (OA) of the knee for a minimum of 6 months will be recruited for this study. Their OA has not responded/is not responding to treatment and continuing symptoms interfere with normal function. Additionally, patients will have a pain score of 3 or greater on the NRS even with pain medication.
Secondary objectives include changes in:
- Mobility via a Timed Up & Go assessment (TUG). Participants are timed getting up from sitting in a standard armchair, walking approximately 3 meters, turning, walking back to the chair, and sitting down.
- Patient-relevant outcomes via the Knee Injury and Osteoarthritis Outcome Score (KOOS). The KOOS is self-administered and assesses five outcomes: pain, symptoms, activities of daily living, sport and recreation function, and knee-related quality of life.
- Brief Pain Inventory - Short Form
- Use of pain medication.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Arelly Villarreal, BS
- Phone Number: 2145752820
- Email: arelly@avazzia.com
Study Contact Backup
- Name: Elonm M Gbedey, BA
- Phone Number: 2148570304
- Email: elonm.gbedey@va.gov
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75216
- Recruiting
- Veteran Affairs North Texas Healthcare System
-
Contact:
- Elomn M Gbedey
- Phone Number: 214-857-0304
- Email: elomn.gbedey@va.gov
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Have a prior diagnosis (Dx) of OA of the knee and have had a trial of conservative treatment for a minimum of 6 months without successful results due to continuing symptoms that interfere with normal function
- Age >18 - <70 years old
- Males/Females of all ethnicities
- NRS pain score of 3 or greater while on medication
- Ability to understand the informed consent document before signing it
- For female participants, is at least 4 years post-menopausal, has a history of hysterectomy, has had bilateral tubal ligation, or consents to use two forms of birth control.
Exclusion Criteria:
- Poor diabetic control (A1c>11 within the last 3 months)
- Diagnosis of acute sciatica and/or acute vasculitis
- Diabetic peripheral neuropathy
- Lower extremity surgery within the last 6 months
- Knee replacement
- Uncontrolled mood disorders, such as depression, anxiety
- Drug or substance abuse within past 90 days
- Injury that results in a change in pain level due to causes other than osteoarthritis (i.e., a recent fall or accident)
- Epilepsy
- Open wounds around knee joint
- Active litigation, workers compensation
- An electrically implanted device such as a pacemaker, neural stimulator, etc.
- Currently pregnant, nursing, or may become pregnant.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental: BEST™ Pro-Sport Ultra® microcurrent device
Participants will receive 2 treatments a week on nonconsecutive days for 6 weeks in the clinic with an active electrical stimulation device.
|
Participants will receive two (2) 20-minute treatments a week on nonconsecutive days for 6 weeks in the clinic. At the end of 6 weeks, participants will have a 6-week pause in treatment. Active Avazzia PRO-Sport Ultra® medical device, BEST™ HVPC microcurrent electrical stimulation, FDA cleared for pain relief |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain Level Assessment
Time Frame: 12 weeks
|
Change in pain associated with osteoarthritis of the knee during all visits (#1-13).
Pain will be assessed with NRS (numeric rating scale) where 0 is no pain and 10 is worst possible pain.
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in mobility
Time Frame: 12 weeks
|
Mobility will be assessed via Timed Up & Go (TUG) assessment during visits #1, 12, 13.
Participants are timed getting up from sitting in a standard armchair, walking approximately 3 meters, turning, walking back to the chair, and sitting down.
|
12 weeks
|
Changes in patient-relevant outcomes
Time Frame: 12 weeks
|
Patient-relevant outcomes will be assessed via the Knee Injury and Osteoarthritis Outcome Score (KOOS) during visits #1, 12 and 13.
The KOOS is self-administered and assesses five outcomes: pain, symptoms, activities of daily living, sport and recreation function, and knee-related quality of life.
KOOS does not use a numerical scale, it uses a qualitative scale with the following options: never, rarely, sometimes, often and always.
|
12 weeks
|
Changes in brief pain inventory
Time Frame: 12 weeks
|
The brief pain inventory (BPI) will be used to assess changes in pain during visits #1, 12, and 13.
This scale ranges from 0 to 10.
The numerical value 0 can represent "no pain" or "does not interfere".
The numerical value 10 can represent "pain as bad as you can imagine" or completely interferes".
|
12 weeks
|
Changes in the use of pain medication
Time Frame: 12 weeks
|
Medication usage will be recorded during visits #1, 12, 13 and any increase/decrease in pain medications will be assessed.
|
12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Thiru Annaswamy, MD, Veteran Affairs North Texas Healthcare System
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RA-191011-01-VA-OA-Knee
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthritis
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Novartis PharmaceuticalsRecruitingSymptomatic Knee OsteoarthritisUnited States, Spain, Hungary, Argentina, Germany, Slovakia, Czechia, Belgium, Romania
-
University of BathUniversity of Oxford; 3D Metal Printing Ltd; Versus ArthritisRecruitingMedial Knee OsteoarthritisUnited Kingdom
-
Max Biocare Pty. Ltd.Completed
Clinical Trials on BEST™ HVPC microcurrent electrical stimulation Pro-Sport Ultra® device
-
Avazzia, IncJoseph Surace, D.C.Active, not recruitingCarpal Tunnel SyndromeUnited States
-
Tripler Army Medical CenterUniversity of VirginiaUnknownRestless Legs SyndromeUnited States
-
RS MedicalAccelerated Care Plus; Research Institute of Health and Science (RIHSE)Completed